Efficacy of ChemoID® guided drug selection for palliative chemotherapy in advanced recurrent high-grade ovarian adenocarcinoma: Case study. Translational Medicine Reports, [S. l.], v. 2, n. 1, 2017. DOI: 10.4081/tmr.6701. Disponível em: https://www.pagepressjournals.org/tmr/article/view/6701. Acesso em: 14 may. 2026.